Correlation Between Central Reinsurance and GeneReach Biotechnology

Can any of the company-specific risk be diversified away by investing in both Central Reinsurance and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Central Reinsurance and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Central Reinsurance Corp and GeneReach Biotechnology, you can compare the effects of market volatilities on Central Reinsurance and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Central Reinsurance with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Central Reinsurance and GeneReach Biotechnology.

Diversification Opportunities for Central Reinsurance and GeneReach Biotechnology

0.21

Correlation Coefficient

Central Reinsurance  GeneReach Biotechnology

Modest diversification

The 3 months correlation between Central and GeneReach is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Central Reinsurance Corp and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Central Reinsurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Central Reinsurance Corp are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Central Reinsurance i.e., Central Reinsurance and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Central Reinsurance and GeneReach Biotechnology

Assuming the 90 days trading horizon Central Reinsurance Corp is expected to generate 0.57 times more return on investment than GeneReach Biotechnology. However, Central Reinsurance Corp is 1.77 times less risky than GeneReach Biotechnology. It trades about 0.01 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.12 per unit of risk. If you would invest  2,585  in Central Reinsurance Corp on October 8, 2024 and sell it today you would earn a total of  10.00  from holding Central Reinsurance Corp or generate 0.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Central Reinsurance Corp  vs.  GeneReach Biotechnology

Central Reinsurance Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Central Reinsurance Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Central Reinsurance is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Central Reinsurance and GeneReach Biotechnology

The main advantage of trading using opposite Central Reinsurance and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Central Reinsurance position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.

The idea behind Central Reinsurance Corp and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.